|
Volumn 18, Issue 11, 2003, Pages 2241-2244
|
Issues to debate on the Women's Health Initiative (WHI) study. Epidemiology or randomized clinical trials - Time out for hormone replacement therapy studies?
|
Author keywords
Cardiovascular disease; HRT; Women's Health Initiative Study
|
Indexed keywords
ESTROGEN;
GESTAGEN;
SEX HORMONE;
BREAST CANCER;
CANCER RISK;
CARDIOVASCULAR DISEASE;
CLINICAL OBSERVATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DIABETES MELLITUS;
DRUG CONTRAINDICATION;
EPIDEMIOLOGICAL DATA;
ESTROGEN THERAPY;
EVIDENCE BASED MEDICINE;
FEMALE;
HIGH RISK PATIENT;
HORMONE SUBSTITUTION;
HUMAN;
HYPERTENSION;
ISCHEMIC HEART DISEASE;
LONG TERM CARE;
MEDICAL DECISION MAKING;
MENOPAUSE RELATED DISORDER;
POSTMENOPAUSE;
PREVENTIVE HEALTH SERVICE;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SHORT SURVEY;
VALIDATION PROCESS;
|
EID: 0242522164
PISSN: 02681161
EISSN: None
Source Type: Journal
DOI: 10.1093/humrep/deg435 Document Type: Short Survey |
Times cited : (19)
|
References (7)
|